Li Cai

Li Cai

Directeur/Membre du Conseil chez DINGDANG HEALTH TECHNOLOGY GROUP LTD.

40 ans
Health Technology
Commercial Services
Finance

Profil

Li Cai is currently the Vice Chairman at Hangzhou Kangji Medical Instrument Co., Ltd., the Managing Director at TPG Capital Asia Inc, the Director at Novotech (Australia) Pty Ltd., the Director at Biosuntek Laboratory Co. Ltd., the Director at Zhejiang Choisun Tea Development Co. Ltd., the Non-Executive Director at Kangji Medical Holdings Ltd., the Director at Opc Co. Holdings Cayman Islands Ltd., the Director at Opc Intermediate Holding Co. Cayman Islands Ltd., the Director at Ppc Kk Japan Ltd., the Director at Apluscro Pte Ltd., the Director at Ppc Korea Ltd., the Director at Ppc China Corp.
Ltd., the Director at Ppc China Clinical Research Corp.
Ltd., the Director at Jiasheng Shanghai Pharmaceutical Consulting Co. Ltd., the Director at Aplus Pharmaceutical Consulting Shanghai Co. Ltd., the Director at Bailixing Xiamen Equity Investment Co. Ltd., the Director at Acrostar Pharmaservices Corp., the Director at Acrostar Site Management Co. Ltd., the Director at Novotech Holdings Pty Ltd., the Director at Novotech Aus Holdco Pty Ltd., the Non-Executive Director at Novotech Health Holdings Ltd., the Non-Executive Director at Dingdang Health Technology Group Ltd., the Director at Ppc Holding Co., the Non-Executive Director at Chongho Bridge Ltd., the Director at Novotech Laboratory Services Shanghai Co. Ltd., the Principal at TPG Capital-China Ltd., and a Member-Supervisory Board at Shanghai Deyu Deqi Enterprise Management Consulting Co. Ltd.
Ms. Cai previously worked as a Non-Executive Director at Zhaoke Ophthalmology Ltd.
from 2020 to 2023, a Non-Executive Director at Shanghai Bio-Heart Biological Technology Co., Ltd.
from 2020 to 2022, and an Investment Associate at Hao Capital Co. Ltd.
from 2009 to 2011.
Ms. Cai completed their undergraduate degree at Yale University in 2017.

Postes actifs de Li Cai

SociétésPosteDébut
KANGJI MEDICAL HOLDINGS LIMITED Directeur/Membre du Conseil 13/03/2020
DINGDANG HEALTH TECHNOLOGY GROUP LTD. Directeur/Membre du Conseil 26/05/2021
Analyste en capital-investissement 01/01/2011
Ppc Korea Ltd. Directeur/Membre du Conseil 01/08/2017
Ppc Holding Co. Directeur/Membre du Conseil 01/08/2017
Directeur/Membre du Conseil 02/12/2020
Novotech Aus Holdco Pty Ltd. Directeur/Membre du Conseil 01/07/2020
Directeur/Membre du Conseil 01/07/2020
Acrostar Site Management Co. Ltd. Directeur/Membre du Conseil 01/01/2019
░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Tous les postes actifs de Li Cai

Anciens postes connus de Li Cai

SociétésPosteFin
░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░ ░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Li Cai

Formation de Li Cai

Yale University Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Li Cai

Relations

98

Relations au 1er degré

29

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées4
SHANGHAI BIO-HEART BIOLOGICAL TECHNOLOGY CO., LTD.

Commercial Services

ZHAOKE OPHTHALMOLOGY LIMITED

Health Technology

KANGJI MEDICAL HOLDINGS LIMITED

Health Technology

DINGDANG HEALTH TECHNOLOGY GROUP LTD.

Technology Services

Entreprise privées24

Finance

Apluscro Pte Ltd.

Health Technology

Hao Capital Co. Ltd.

Finance

Commercial Services

Finance

Distribution Services

Zhejiang Choisun Tea Development Co. Ltd.

Shanghai Deyu Deqi Enterprise Management Consulting Co. Ltd.

Opc Co. Holdings Cayman Islands Ltd.

Opc Intermediate Holding Co. Cayman Islands Ltd.

Ppc Kk Japan Ltd.

Commercial Services

Ppc Korea Ltd.

Ppc China Clinical Research Corp. Ltd.

Jiasheng Shanghai Pharmaceutical Consulting Co. Ltd.

Aplus Pharmaceutical Consulting Shanghai Co. Ltd.

Bailixing Xiamen Equity Investment Co. Ltd.

Acrostar Pharmaservices Corp.

Acrostar Site Management Co. Ltd.

Commercial Services

Novotech Aus Holdco Pty Ltd.

Health Technology

Ppc Holding Co.

Voir les connexions sociétés
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT